HLVX
Price:
$2.09
Market Cap:
$104.76M
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
HLVX
According to HilleVax, Inc.’s latest financial reports and current stock price. The company's current ROE is -44.61%. This represents a change of 309.59% compared to the average of -10.89% of the last 4 quarters.
The mean historical ROE of HilleVax, Inc. over the last ten years is 3.92%. The current -44.61% ROE has changed -1237.50% with respect to the historical average. Over the past ten years (40 quarters), HLVX's ROE was at its highest in in the September 2021 quarter at 97.43%. The ROE was at its lowest in in the June 2022 quarter at -31.35%.
Average
3.92%
Median
15.17%
Minimum
-96.17%
Maximum
100.30%
Discovering the peaks and valleys of HilleVax, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 104.84%
Maximum Annual ROE = 100.30%
Minimum Annual Increase = -213.97%
Minimum Annual ROE = -96.17%
| Year | ROE | Change |
|---|---|---|
| 2024 | -95.33% | 104.84% |
| 2023 | -46.54% | -51.61% |
| 2022 | -96.17% | -213.97% |
| 2021 | 84.39% | 9.76% |
| 2020 | 76.88% | -23.34% |
The current ROE of HilleVax, Inc. (HLVX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-79.35%
5-year avg
-15.35%
10-year avg
3.92%
HilleVax, Inc.’s ROE is greater than Jounce Therapeutics, Inc. (-25.03%), greater than RVL Pharmaceuticals plc (-80.88%), greater than Tourmaline Bio, Inc. (-30.50%), greater than Cyteir Therapeutics, Inc. (-26.35%), greater than Aadi Bioscience, Inc. (-8.09%), less than Opiant Pharmaceuticals, Inc. (7.31%), greater than Insight Molecular Diagnostics Inc. (-2898.07%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Miromatrix Medical Inc. (-74.80%), greater than Berkeley Lights, Inc. (-55.98%),
| Company | ROE | Market cap |
|---|---|---|
| -25.03% | $98.95M | |
| -80.88% | $3.14M | |
| -30.50% | $1.23B | |
| -26.35% | $108.71M | |
| -8.09% | $94.89M | |
| 7.31% | $108.80M | |
| -2898.07% | $159.95M | |
| -56.38% | $123.37M | |
| -74.80% | $92.95M | |
| -55.98% | $86.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HilleVax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HilleVax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is HilleVax, Inc.'s ROE?
How is the ROE calculated for HilleVax, Inc. (HLVX)?
What is the highest ROE for HilleVax, Inc. (HLVX)?
What is the 3-year average ROE for HilleVax, Inc. (HLVX)?
What is the 5-year average ROE for HilleVax, Inc. (HLVX)?
How does the current ROE for HilleVax, Inc. (HLVX) compare to its historical average?